M&A Deal Summary |
|
|---|---|
| Date | 2008-01-02 |
| Target | Imperial Chemical Industries |
| Sector | Chemicals |
| Buyer(s) | Akzo Nobel |
| Deal Type | Add-on Acquisition |
| Deal Value | 8.0B GBP |
SEARCH BY
Try For Free 7-Day Free Trial
| Category | Company |
|---|---|
| Founded | 1646 |
| Sector | Chemicals |
| Employees | 36,100 |
| Revenue | 9.6B EUR (2021) |
Akzo Nobel is a producer of decorative paints, performance coatings and specialty chemicals. Akzo Nobel was founded in 1646 and is based in Amsterdam, the Netherlands.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 9 |
| Sector (Chemicals) | 1 of 7 |
| Type (Add-on Acquisition) | 1 of 8 |
| Country (United Kingdom) | 1 of 2 |
| Year (2008) | 1 of 1 |
| Size (of disclosed) | 1 of 2 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2007-11-19 |
Organon BioSciences N.V.
Oss, Netherlands Organon BioSciences N.V. is a human health business, and Intervet, an animal health business. It also includes Nobilon, a human vaccine development unit, and Diosynth, a third-party manufacturing unit of Organon. |
Sell | €11.0B |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2009-09-23 |
Akzo Nobel - Iron Coagulant Business
Denmark Akzo Nobel - Iron Coagulant Business in Sweden, Norway and Denmark comprises operations that engage in the sales of iron coagulants used for water treatment purposes. The business is located in Sweden, Norway and Denmark. |
Sell | - |
